Remember meForgot password?
    Log in with Twitter

branded drug News

Op-Ed: Mylan's $465 million EpiPen settlement to Medicaid is laughable

Drug-maker Mylan has agreed to pay $465 million to settle allegations that it over-billed Medicaid for its life-saving EpiPen, all without their admitting any guilt, and closing the book on a federal investigation.

Search Digital Journal Archives

Set up a news alert for

branded drug

branded drug Image

Latest News
Top News